Eun Ju Ha, Min Kyoung Lee, Jung Hwan Baek, Hyun Kyung Lim, Hye Shin Ahn, Seon Mi Baek, Yoon Jung Choi, Sae Rom Chung, Ji-Hoon Kim, Jae Ho Shin, Ji Ye Lee, Min Ji Hong, Hyun Jin Kim, Leehi Joo, Soo Yeon Hahn, So Lyung Jung, Chang Yoon Lee, Jeong Hyun Lee, Young Hen Lee, Jeong Seon Park, Jung Hee Shin, Jin Yong Sung, Miyoung Choi, Dong Gyu Na
{"title":"射频消融治疗复发性甲状腺癌：2025韩国甲状腺放射学会指南。","authors":"Eun Ju Ha, Min Kyoung Lee, Jung Hwan Baek, Hyun Kyung Lim, Hye Shin Ahn, Seon Mi Baek, Yoon Jung Choi, Sae Rom Chung, Ji-Hoon Kim, Jae Ho Shin, Ji Ye Lee, Min Ji Hong, Hyun Jin Kim, Leehi Joo, Soo Yeon Hahn, So Lyung Jung, Chang Yoon Lee, Jeong Hyun Lee, Young Hen Lee, Jeong Seon Park, Jung Hee Shin, Jin Yong Sung, Miyoung Choi, Dong Gyu Na","doi":"10.3348/kjr.2024.0963","DOIUrl":null,"url":null,"abstract":"<p><p>Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.</p>","PeriodicalId":17881,"journal":{"name":"Korean Journal of Radiology","volume":"26 1","pages":"10-28"},"PeriodicalIF":4.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717866/pdf/","citationCount":"0","resultStr":"{\"title\":\"Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline.\",\"authors\":\"Eun Ju Ha, Min Kyoung Lee, Jung Hwan Baek, Hyun Kyung Lim, Hye Shin Ahn, Seon Mi Baek, Yoon Jung Choi, Sae Rom Chung, Ji-Hoon Kim, Jae Ho Shin, Ji Ye Lee, Min Ji Hong, Hyun Jin Kim, Leehi Joo, Soo Yeon Hahn, So Lyung Jung, Chang Yoon Lee, Jeong Hyun Lee, Young Hen Lee, Jeong Seon Park, Jung Hee Shin, Jin Yong Sung, Miyoung Choi, Dong Gyu Na\",\"doi\":\"10.3348/kjr.2024.0963\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.</p>\",\"PeriodicalId\":17881,\"journal\":{\"name\":\"Korean Journal of Radiology\",\"volume\":\"26 1\",\"pages\":\"10-28\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717866/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Journal of Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3348/kjr.2024.0963\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3348/kjr.2024.0963","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline.
Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.
期刊介绍：
The inaugural issue of the Korean J Radiol came out in March 2000. Our journal aims to produce and propagate knowledge on radiologic imaging and related sciences.
A unique feature of the articles published in the Journal will be their reflection of global trends in radiology combined with an East-Asian perspective. Geographic differences in disease prevalence will be reflected in the contents of papers, and this will serve to enrich our body of knowledge.
World''s outstanding radiologists from many countries are serving as editorial board of our journal.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
